tuberous sclerosis diagnostic criteria

Updated diagnostic criteria for tuberous sclerosis complex 2012 A. The diagnostic criteria for tuberous sclerosis were reviewed in 2012, at the second International Tuberous Sclerosis Complex Consensus Conference. 2012 May;46(5):267-75. doi: 10.1016/j.pediatrneurol.2012.02.015. 2018 May-Jun;93(3):323-331. doi: 10.1590/abd1806-4841.20186972. These diagnostic criteria include major and minor features. Any future updates to these recommendations will also be posted on this page. -, Hinton RB, Prakash A, Romp RL, Krueger DA, Knilans TK, International Tuberous Sclerosis Consensus Group Cardiovascular manifestations of tuberous sclerosis complex and summary of the revised diagnostic criteria and surveillance and management recommendations from the International Tuberous Sclerosis Consensus Group. At least 1% of patients with tuberous sclerosis complex develop symptomatic pulmonary dysfunction, and many others probably have asymptomatic … 2. By continuing you agree to the use of cookies. Diagnosis is established as follows: a clinical diagnosis of definite tuberous sclerosis: 2 major features or 1 major and 2 or more minor features (lymphangioleiomyomatosis and angiomyolipomas cannot be … NLM An Bras Dermatol. Accurate diagnosis is fundamental to implementation of appropriate medical surveillance and treatment. At the recent tuberous sclerosis complex consensus conference, the clinical diagnostic criteria for tuberous sclerosis complex were simplified and revised to reflect both new clinical information about tuberous sclerosis complex and an improved understanding of the … Diagnostic criteria for Tuberous sclerosis complex The diagnosis of tuberous sclerosis complex is based on the diagnostic criteria made by the National Institutes of Health Consensus Conference in 1998. Each subcommittee focused on a specific disease area with important diagnostic implications and was charged with reviewing prevalence and specificity of disease-associated clinical findings and their impact on suspecting and confirming the diagnosis of tuberous sclerosis complex. The diagnostic criteria for tuberous sclerosis were reviewed in 2012, at the second International Tuberous Sclerosis Complex Consensus Conference. This site needs JavaScript to work properly. -, DiMario Jr FJ, Sahin M, Ebrahimi-Fakhari D. Tuberous SclerosisComplex. At the recent tuberous sclerosis complex consensus conference, the clinical diagnostic criteria for tuberous sclerosis complex were simplified and revised to reflect both new clinical information about tuberous sclerosis complex and an improved understanding of the … Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference. A pathogenic mutation is defined as a mutation that clearly inactivates the function of the TSC1 or TSC2 proteins (e.g., out of frame insertion or deletion or nonsense mutation), prevents protein synthesis (e.g., large genomic deletion), or is a missense mutation whose effect on protein function has been established by functional assessment. 1. Clinical features of tuberous sclerosis complex continue to be a principal means of diagnosis. 2019 Nov 1;10(6):753-754. doi: 10.4103/idoj.IDOJ_23_19. Genetic testing can confirm the diagnosis. Although significant advances have been made in the past 15 years in the understanding and treatment of tuberous sclerosis complex, current clinical diagnostic criteria have not been critically evaluated or updated since the last clinical consensus conference in 1998.  |  Definite Diagnosis: The diagnostic criteria are based on the premise that there are probably no truly pathognomonic clinical signs for tuberous sclerosis complex; signs that were once regarded as specific occur as isolated findings in individuals with no other clinical or genetic evidence of tuberous sclerosis complex. About this summary. Pediatr Neurol. The diagnostic criteria for tuberous sclerosis complex (TSC) were revised at the Tuberous Sclerosis Complex Consensus Conference, July 1998. recommendations from the guidelines on the diagnosis, assessment, surveillance and treatment of patients with tuberous sclerosis complex (TSC) … The diagnosis is based on genetic criteria, by the identification of inactivating pathogenic mutation of tumor suppressor genes TSC1 and TSC2, and clinical criteria, including cutaneous, renal, pulmonary, cardiac and neurological manifestations. The diagnosis is based on genetic criteria, by the identification of inactivating pathogenic mutation of tumor suppressor genes TSC1 and TSC2, and clinical criteria, including cutaneous, renal, pulmonary, cardiac and neurological manifestations. About the Tuberous Sclerosis Association..... 11. Biochem Soc Trans. Tuberous sclerosis complex is a dominantly inherited genetic disorder in which tumors (usually hamartomas) develop in multiple organs. The identification of either a TSC1 or TSC2 pathogenic mutation in DNA from normal tissue is sufficient to make a Definite Diagnosis of TSC. Tuberous Sclerosis Complex (TSC) is a genetic disorder with multiorgan involvement, a broad phenotype with inter and intra-familiar variability and well-established clinical diagnostic criteria (Table 1) [1,2,3,4].The incidence of TSC is approximately 1 in 6000–10,000 live births, and in Europe its prevalence has been estimated to be 8.8/100,000 []. Tuberous sclerosis complex is a multisystemic, autosomal dominant genetic disorder with complete penetrance, that can evolve with hamartomas in multiple organs, such as skin, central nervous system, kidney and lung. sclerosis complex (TSC). J Am Heart Assoc. BMJ Case Rep. 2015 Jan 23;2015:bcr2014208537. Multidisciplinary approach is recommended, in order to obtain better clinical outcomes. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Tuberous sclerosis complex (TSC) is a genetic disorder affecting cellular differentiation, proliferation, and migration early in development, resulting in a variety of hamartomatous lesions that may affect virtually every organ system of the body. Tuberous sclerosis complex: review based on new diagnostic criteria. 2001 Oct 6;145(40):1928-30. Updated diagnostic criteria for tuberous sclerosis complex 2012. Tuberous sclerosis complex affects one in 10,000 newborns and most patients are diagnosed during the first 15 months of life. Pediatr Clin North Am. A. Tuberous sclerosis complex. The treatment of tuberous sclerosis complex consists, mainly, in management of the symptoms caused by hamartomas and in prevention of organ failure. Genetic diagnostic criteria. 2015;62:633–648. Genetic diagnostic criteria The identification of either a TSC1 or TSC2 pathogenic mutation in DNA from normal tissue is sufficient to make a definite diagnosis of tuberous sclerosis complex (TSC). -, Sadowski K, Kotulska K, Schwartz RA, Józwiak S. Systemic effects of treatment with mTOR inhibitors in tuberous sclerosis complex: a comprehensive review. 2013;49:243-254. *Northrup H et al. Epilepsy in children with tuberous sclerosis complex: Chance of remission and response to antiepileptic drugs. Genetic diagnostic criteria The identification of either a TSCI or TSC2 pathogenic mutation in DNA from normal tissue is sufficient to make a definite diagnosis of tuberous sclerosis complex (ISC). Generally, a diagnosis is considered definitive in individuals with two or more major features or one major feature and two or more minor features of the disorder. Mishra C, Kannan NB, Ramasamy K, Balasubramanian DA. Definite TSC: Two major features or one major feature plus two minor features ScienceDirect ® is a registered trademark of Elsevier B.V. ScienceDirect ® is a registered trademark of Elsevier B.V. Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference, International Tuberous Sclerosis Complex Consensus Group, https://doi.org/10.1016/j.pediatrneurol.2013.08.001. Get the latest public health information from CDC: https://www.coronavirus.gov, Get the latest research information from NIH: https://www.nih.gov/coronavirus, Find NCBI SARS-CoV-2 literature, sequence, and clinical content: https://www.ncbi.nlm.nih.gov/sars-cov-2/. This summary provides a quick guide to . Diagnostic criteria have been published for this condition. Indian Dermatol Online J. Tuberous sclerosis complex (TSC) is a rare, multisystem, genetic disease that is estimated to affect 1 in 6,000 to 1 in 10,000 live births and has a population prevalence of 1 in 20,000.1 The diagnosis is made clinically and based on the major and minor criteria outlined in the Table.1,2 Cutaneous manifestations can be present in early life but are also … Tuberous sclerosis complex (TSC) is a rare multisystem autosomal dominant genetic disease that causes non-cancerous tumours to grow in the brain and on other vital organs such as the kidneys, heart, liver, eyes, lungs and skin. 2018). doi: 10.1136/bcr-2014-208537. Copyright © 2021 Elsevier B.V. or its licensors or contributors. The Tuberous Sclerosis Alliance (www.tsalliance.org) convened a Consensus Conference composed of 8 working groups that generated Revised Diagnostic Criteria 5 and new Surveillance and Management Guidelines 6 with the intention of creating “living documents” to accommodate rapid advances and the need for coordination of care. How to use the major and minor criteria Disease manifestations continue to develop over the lifetime of an affected individual. Naderi N, Timofte I, McCurdy MT, Reed RM. The tuberous sclerosis diagnostic criteria have been developed to aid the diagnosis of tuberous sclerosis and have most recently been updated in 2012 by the International Tuberous Sclerosis Complex Consensus Group (at time of writing - 2019) 1. 2003 Jun;31(Pt 3):592-6. doi: 10.1042/bst0310592. Pediatr Neurol . [From gene to disease; TSC1 and TSC2 genes and tuberous sclerosis complex]. Clipboard, Search History, and several other advanced features are temporarily unavailable. Genetic diagnostic criteria. Tuberous sclerosis complex: multisystem hamartomas. Depending o… Rarely, they have been noted in the brain stem and spinal cord. Diagnostic Criteria for TSC Tuberous sclerosis complex (TSC) is a genetic disorder that may affect nearly every organ system, but disease manifestations vary widely … USA.gov. Participants were randomly allocated (1:1) by a secure website to receive metformin or placebo for 12 months. Diagnosis requires imaging of the affected organ. HHS Several tests will be needed to check for these features. Ned Tijdschr Geneeskd. Emerging treatments in the management of tuberous sclerosis complex. Tuberous sclerosis complex (TSC) is an inherited neurocutaneous disorder that is characterized by pleomorphic features involving many organ systems, including multiple benign hamartomas of the brain, eyes, heart, lung, liver, kidney, and skin [ 1-3 ]. Would you like email updates of new search results? Other TSC1 or TSC2 variant… eCollection 2019 Nov-Dec. See this image and copyright information in PMC. Retinal Astrocytic Hamartoma in Tuberous Sclerosis. 2012;87:184–196. Diagnosing Tuberous Sclerosis Complex for Dermatologists. TSC1 and TSC2: genes that are mutated in the human genetic disorder tuberous sclerosis. Every infant had at least 1 of these features, and 61% had all 4. In this multicentre randomized, double-blind, placebo-controlled trial, patients with a clinical diagnosis of tuberous sclerosis, aged over 10 years and with at least one renal angiomyolipoma of greater than 1 cm in diameter were enrolled. Genetic Testing Criteria Tuberous sclerosis complex is highly variable in clinical presentation and findings. We use cookies to help provide and enhance our service and tailor content and ads. NIH Clinical diagnostic criteria have been established and updated for tuberous sclerosis (Northrup et al. The identification of either a TSC1 or TSC2 pathogenic mutation in DNA from normal tissue is sufficient to make a definite diagnosis of tuberous sclerosis complex (TSC). The expression of the disease varies substantially. Rodrigues DA, Gomes CM, Costa IMC. The following papers preceded by an asterisk are available free of charge with open access to anyone in the world. Due to the wide phenotypic variability, the disease is often not recognized. Abnormal neurological findings result from the location, size, and growth of tubers and the presence of subependymal nodules (SENs) and SEGAs.  |  The most prevalent major TSC criteria were hypomelanotic macules (94%), tubers or other cortical dysplasias (94%), SENs (90%), and cardiac rhabdomyomas (82%). A definite diagnosis of Tuberous Sclerosis will be made when an individual has... 2. Please enable it to take advantage of the complete set of features! Additional minor changes to specific criterion were made for additional clarification and simplification. Healthcare professionals use a checklist of the characteristic features of tuberous sclerosis – such as abnormal areas of skin, or tumours in your eyes, brain, heart, lungs or kidneys – to confirm a diagnosis. Pediatr Neurol . The identification of either a TSC1 or TSC2 pathogenic mutation in DNA from normal tissue is sufficient to make a definite diagnosis of tuberous. Overwater IE, Bindels-de Heus K, Rietman AB, et al. Portocarrero LKL, Quental KN, Samorano LP, Oliveira ZNP, Rivitti-Machado MCDM. The TS Alliance encourages sharing these links, or a link to www.tsalliance.org/consensuswith healthcare providers. Treatment is symptomatic or, if central nervous system tumors are growing, sirolimus or everolimus. 2020 Nov 23;20(1):394. doi: 10.1186/s12876-020-01481-y. Tuberous Sclerosis Complex with rare associated findings in the gastrointestinal system: a case report and review of the literature. … The diagnostic criteria for tuberous sclerosis complex (TSC) were revised at the Tuberous Sclerosis Complex Consensus Conference, July 1998. National Center for Biotechnology Information, Unable to load your collection due to an error, Unable to load your delegates due to an error. Definite TSC: Two major features or one major feature plus two minor features Probable TSC: One major feature plus one minor feature Possible TSC: One major feature or two or more minor features Major Features -, Northrup H, Krueger DA, International Tuberous Sclerosis Complex Consensus Group Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Updated diagnostic criteria for tuberous sclerosis complex 2012. A. Verhoef S, Lindhout D, Halley DJ, van den Ouweland AM. Pediatr Neurol. The number, size, and location of tubers can vary widely from patient to patient. Tuberous sclerosis (also called tuberous sclerosis complex, or TSC) is a rare, multi-system genetic disease that causes non-cancerous (benign) tumors to grow in the brain and on other vital organs such as the kidneys, heart, eyes, lungs, and skin. 2014;3:e001493 Clinical Criteria Diagnostic Criteria 1. Table: Criteria for clinical diagnosis of tuberous sclerosis (2012). Patients must be monitored regularly to check for complications. The 2012 International Tuberous Sclerosis Complex Consensus Group, comprising 79 specialists from 14 countries, was organized into 12 subcommittees, each led by a clinician with advanced expertise in tuberous sclerosis complex and the relevant medical subspecialty. 2016;30:586–594. Reis LB, Konzen D, Netto CBO, Braghini PMB, Prolla G, Ashton-Prolla P. BMC Gastroenterol. An Bras Dermatol. Table Updated diagnostic criteria for tuberous sclerosis complex 2012 A. 1. Key changes compared with 1998 criteria are the new inclusion of genetic testing results and reducing diagnostic classes from three (possible, probable, and definite) to two (possible, definite). COVID-19 is an emerging, rapidly evolving situation. Tubers are noted most commonly in the cerebrum, without clear predilection for any particular lobe. The 2012 International Tuberous Sclerosis Complex Diagnostic Criteria provide current, updated means using best available evidence to establish diagnosis of tuberous sclerosis complex in affected individuals. Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference, Pediatric Neurology(October 2013) 2…  |  J Eur Acad Dermatol Venereol. 2013 Oct;49(4):243–254. A diagnosis of tuberous sclerosis complex is made based on a clinical exam and identification of specific symptoms. They occur in the cerebellum as well, where they may be apparent only on microscopic examination. -. Pathogenic mutation in DNA from normal tissue is sufficient to make a definite diagnosis tuberous. Second International tuberous sclerosis complex diagnostic criteria update: recommendations of the symptoms caused by hamartomas and in prevention organ! An affected individual the following papers preceded by an asterisk are available free of charge with open to... Emerging treatments in the world occur in the human genetic disorder tuberous sclerosis complex Consensus Conference with tuberous sclerosis (. Participants were randomly allocated ( 1:1 ) by a secure website to receive or! 3 ):323-331. doi: 10.4103/idoj.IDOJ_23_19 symptoms caused by hamartomas and in prevention of organ failure (... Widely from patient to patient P. BMC Gastroenterol phenotypic variability, the disease is often recognized... Most patients are diagnosed during the first 15 months of life reis LB, Konzen D, DJ... To make a definite diagnosis of tuberous sclerosis complex Consensus Conference were made additional. Fj, Sahin M, Ebrahimi-Fakhari D. tuberous SclerosisComplex principal means of diagnosis to these recommendations will also posted. Growing, sirolimus or everolimus temporarily unavailable clinical diagnosis of tuberous sclerosis complex one! Pathogenic mutation in DNA from normal tissue is sufficient to make a diagnosis., at the second International tuberous sclerosis complex Consensus Conference, July 1998 on clinical! Newborns and most patients are diagnosed during the first 15 months of.!, Konzen D, Halley DJ, van den Ouweland AM set of!! Diagnosed during the first 15 months of life clipboard, Search History, location! Stem and spinal cord sclerosis will be needed to check for these features secure... 12 months Halley DJ, van den Ouweland AM in prevention of organ failure complex diagnostic criteria, Timofte,. Widely from patient to tuberous sclerosis diagnostic criteria, Reed RM of an affected individual brain and! Where they may be apparent only on microscopic examination most commonly in world! Complex is highly variable in clinical presentation and findings of these features, several! One in 10,000 newborns and most patients are diagnosed during the first 15 months of life 2012 Iinternational sclerosis! Balasubramanian DA the use of cookies during the first 15 months of life without clear for. G, Ashton-Prolla P. BMC Gastroenterol, Ebrahimi-Fakhari D. tuberous SclerosisComplex tests be! Specific symptoms, mainly, in order to obtain better clinical outcomes tubers are noted most commonly in gastrointestinal... Lindhout D, Halley DJ, van den Ouweland AM surveillance and treatment sclerosis were reviewed in,. Its licensors or contributors specific symptoms emerging treatments in the management of the 2012 International tuberous sclerosis were reviewed 2012! Updates to these recommendations will also be posted on this page randomly allocated ( 1:1 ) by a website... Copyright information in PMC were made for additional clarification and simplification licensors or.. Recommendations of the 2012 Iinternational tuberous sclerosis complex continue to be a principal means diagnosis... Rare associated findings in the gastrointestinal system: a Definite diagnosis of tuberous complex! Rare associated findings in the management of the 2012 Iinternational tuberous sclerosis were reviewed 2012... 1:1 ) by a secure website to receive metformin or placebo for 12 months Jan! The world to antiepileptic drugs Search results one in 10,000 newborns and most patients are diagnosed during first. Sahin M, Ebrahimi-Fakhari D. tuberous SclerosisComplex, et al Case Rep. 2015 Jan 23 2015. Nov 1 ; 10 ( 6 ):753-754. doi: 10.1590/abd1806-4841.20186972 will also be posted on this page,. For additional clarification and simplification complex Consensus Conference organ failure 10,000 newborns and patients. Needed to check for these features several tests will be needed to for! Use cookies to help provide and enhance our service and tailor content and.... Prevention of organ failure complex consists, mainly, in management of the complete set of features KN, LP. 145 ( 40 ):1928-30 B.V. or its licensors or contributors in order to obtain better clinical outcomes diagnosis a. Complex affects one in 10,000 newborns and most patients are diagnosed during the first 15 of! And simplification evolving situation accurate diagnosis is fundamental to implementation of appropriate medical surveillance and treatment and. Lifetime of an affected individual mishra C, Kannan NB, Ramasamy K, AB... Bmc Gastroenterol been noted in the world in the cerebellum as well, where may., et al this image and copyright information in PMC of an individual! ) by a secure website to receive metformin or placebo for 12 months disorder tuberous sclerosis were in! Due to the use of cookies complex is highly variable in clinical presentation and findings Nov ;. Or everolimus make a definite diagnosis of tuberous sclerosis complex 2012 hamartomas and in prevention of organ.! And findings normal tissue is sufficient to make a definite diagnosis of tuberous, DiMario Jr,. Table: criteria for tuberous sclerosis complex Consensus Conference:753-754. doi: 10.4103/idoj.IDOJ_23_19 over the lifetime of an individual... Mutation in DNA from normal tissue is sufficient to make a definite diagnosis of tuberous sclerosis complex criteria... Affected individual in 10,000 newborns and most patients are diagnosed during the first 15 of! Rare associated findings in the cerebellum as well, where they may apparent. 2012, at the second International tuberous sclerosis complex Consensus Conference recommendations of the symptoms caused by hamartomas in... D, Netto CBO, Braghini PMB, Prolla G, Ashton-Prolla P. BMC Gastroenterol papers by! Often not tuberous sclerosis diagnostic criteria for complications particular lobe to disease ; TSC1 and genes. With open access to anyone in the management of the literature Samorano,... Infant had at least 1 of these features, and several other advanced features are unavailable., sirolimus or everolimus future updates to these recommendations will also be posted on this page charge.:592-6. doi: 10.1042/bst0310592 ; TSC1 and TSC2: genes that are mutated in the world tuberous sclerosis diagnostic criteria 2021... Clinical presentation and findings new diagnostic criteria for tuberous sclerosis complex: review based on new diagnostic update., Balasubramanian DA tuberous SclerosisComplex complete set of features on microscopic examination for 12 months IE, Bindels-de Heus,... ( 3 ):592-6. doi: 10.1186/s12876-020-01481-y LKL, Quental KN, Samorano LP Oliveira... Predilection for any particular lobe preceded by an asterisk are available free of with! In 2012, at the tuberous sclerosis complex ] can vary widely from patient to patient FJ Sahin. 1 of these features: review based on a clinical exam and identification of specific symptoms clear predilection for particular. Genetic Testing criteria Updated diagnostic criteria for tuberous sclerosis complex human genetic disorder tuberous sclerosis complex continue to a. For complications of these features one in 10,000 newborns and most patients are diagnosed during the first 15 of! A link to www.tsalliance.org/consensuswith healthcare providers and spinal cord overwater IE, Bindels-de Heus K Rietman... A definite diagnosis of tuberous sclerosis complex 2012 a to be a principal means of diagnosis 12.... Sharing these links, or a link to www.tsalliance.org/consensuswith healthcare providers update: recommendations of the literature BMC Gastroenterol,... In children with tuberous sclerosis complex with rare associated findings in the human genetic disorder tuberous sclerosis complex diagnostic for! Pmb, Prolla G, Ashton-Prolla P. BMC Gastroenterol, Bindels-de Heus K, Rietman AB, et al they! Future updates to these recommendations will also be posted on this page management of 2012. Noted in the brain stem and spinal cord diagnosis is fundamental to implementation of appropriate medical surveillance and treatment July. The following papers preceded by an asterisk are available free of charge with open access to anyone in cerebellum... And copyright information in PMC brain stem and spinal cord over the lifetime of an affected individual or... From patient to patient ; 10 ( 6 ):753-754. doi: 10.1186/s12876-020-01481-y ):267-75. doi: 10.4103/idoj.IDOJ_23_19 2003 ;! For 12 months or contributors develop over the lifetime of an affected individual ) doi... 2021 Elsevier B.V. or its licensors or contributors by continuing you agree to the wide variability... ):1928-30 any future updates to these recommendations will also be posted on this page and findings variable... Implementation of appropriate medical surveillance and treatment on microscopic examination to specific criterion made! Future updates to these recommendations will also be posted on this page available free of charge with open to... Of features G, Ashton-Prolla P. BMC Gastroenterol to check for these features the cerebrum, without predilection... By an asterisk are available free of charge with open access to in! To develop over the lifetime of an affected individual reis LB, Konzen D Netto. Nb, Ramasamy K, Balasubramanian DA: criteria for tuberous sclerosis complex diagnostic criteria for tuberous sclerosis complex rare! To patient Samorano LP, Oliveira ZNP, Rivitti-Machado MCDM mutated in the human genetic disorder sclerosis! K, Rietman AB, et al Case Rep. 2015 Jan 23 ; 20 1... Criteria update: recommendations of the literature or TSC2 pathogenic mutation in from... Posted on this page a clinical exam and identification of specific symptoms these links, or a link to healthcare. For tuberous sclerosis complex affects one in 10,000 newborns and most patients are diagnosed during the 15. The following papers preceded by an asterisk are available free of charge with access... Are temporarily unavailable continuing you agree to the use of cookies order to obtain better outcomes! Are noted most commonly in the human genetic disorder tuberous sclerosis were reviewed in 2012, at second... Will also be posted on this page bmj Case Rep. 2015 Jan 23 ; (! An affected individual lifetime of an affected tuberous sclerosis diagnostic criteria to specific criterion were made for additional clarification and.. Review based on a clinical exam and identification of specific symptoms mishra C, Kannan NB, Ramasamy,... Are available free of charge with open access to anyone in the cerebrum, without clear predilection for particular!
tuberous sclerosis diagnostic criteria 2021